Clinical Trial: Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease

U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533890) titled 'Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease' on March 19.

Brief Summary: In this study the intestinal microbiome and metabolic profiles of patients with inflammatory bowel disease will be determined upon probiotic intervention.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Inflamatory Bowel Disease

Intervention: OTHER: Probiotic Formula

multi-strain probiotics

OTHER: Observation

Observation

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Insel Gruppe AG, University Hospital Bern

Disclaimer: Curated by HT Syndicati...